Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:

Assignment:Patient CB has a history of strokes Pharmacotherapy for Cardiovascular Disorders Case for Week 2 Assignment Patient CB has a history of strokes.

The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following: • Glipizide 10 mg po daily • HCTZ 25 mg daily • Atenolol 25 mg po daily • Hydralazine 25 mg qid • Simvastatin 80 mg daily • Verapamil 180 mg CD daily To Prepare • Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece. • Review the case study assigned by your Instructor for this Assignment. • Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.

• Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes. • Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy. • Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient. Write a 2- to 3-page paper that addresses the following: • Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.

• Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples. • Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements. Changes of the cardiovascular system can cause serious adverse events and may lead to death when not treated in a timely and safe manner. Many of the conditions are “silent killers” and many patients with cardiovascular disorders are unaware until complications appear. An estimated 68 million people in the United States have high blood pressure. However, about 30 percent of these patients are not treated at all, and of those who are treated, more than 50% of those have uncontrolled hypertension.

In clinical settings, patients often present with symptoms of hypertension and other cardiovascular disorders making it essential for you, as the APN, to be able to recognize these symptoms and recommend appropriate pharmacotherapeutic options. This week you will examine the impact of changes in pharmacokinetic and pharmacodynamic processes on patient drug therapy for cardiovascular disorders. You will also explore ways to improve drug therapy plans for these disorders. This week’s learning objectives are as follows: • Evaluate the influence of patient factors on pharmacokinetic and pharmacodynamics processes • Analyze the impact of changes in pharmacokinetic and pharmacodynamic processes on patient drug therapy • Evaluate drug therapy plans for cardiovascular disorders • Understand and apply key terms, concepts, and principles related to prescribing drugs to treat cardiovascular disorders

Rubric Detail

Excellent Good Fair Poor
Explain how the
factor you
selected might
inuence the
pharmacokinetic
and
pharmacodynamic
processes in the
patient from the
case study you
were assigned.
23 (23%) – 25 (25%)
The response
accurately and
completely
explains in detail
how the factor
selected might
inuence the
pharmacokinetic
and
pharmacodynamic
processes in the
patient.
20 (20%) – 22 (22%)
The response
provides a basic
explanation of
how the factor
selected might
inuence the
pharmacokinetic
and
pharmacodynamic
processes in the
patient.
18 (18%) – 19 (19%)
The response
inaccurately or
vaguely explains
how the factor
selected might
inuence the
pharmacokinetic
and
pharmacodynamic
processes in the
patient.
0 (0%) – 17 (17%)
The response
inaccurately and
vaguely explains
how the factor
selected might
inuence the
pharmacokinetic
and
pharmacodynamic
processes in the
patient, or is
missing.
Describe how
changes in the
processes might
impact the
patient’s
recommended
drug therapy. Be
specic and
provide examples.
27 (27%) – 30 (30%)
The response
accurately and
completely
describes in detail
how changes in
the processes
might impact the
patient’s
recommended
drug therapy.
Accurate,
complete, and
aligned examples
are provided to
support the
response.
24 (24%) – 26 (26%)
The response
accurately
describes how
changes in the
processes might
impact the
patient’s
recommended
drug therapy.
Accurate
examples may be
provided to
support the
response.
21 (21%) – 23 (23%)
The response
inaccurately or
vaguely describes
how changes in
the processes
might impact the
patient’s
recommended
drug therapy.
Inaccurate or
vague examples
are provided to
support the
response.
0 (0%) – 20 (20%)
The response
inaccurately and
vaguely describes
how changes in
the processes
might impact the
patient’s
recommended
drug therapy, or is
missing.
Inaccurate and
vague examples
may be provided
to support the
response, or is
missing.
Name: NURS_6521_Week2_Assignment_Rubric EXIT
Grid View List View
Excellent Good Fair Poor
Explain how you
might improve the
patient’s drug
therapy plan, and
explain why you
would make these
recommended
improvements.
27 (27%) – 30 (30%)
The response
accurately and
clearly explains in
detail how to
improve the
patient’s drug
therapy plan.
The response
includes an
accurate and
detailed
explanation to
support the
recommended
improvements.
24 (24%) – 26 (26%)
The response
accurately
explains how to
improve the
patient’s drug
therapy plan.
The response may
include an
accurate
explanation to
support the
recommended
improvements.
21 (21%) – 23 (23%)
The response
inaccurately or
vaguely explains
how to improve
the patient’s drug
therapy plan.
The response may
include an
inaccurate, vague,
or misaligned
explanation to
support the
recommended
improvements.
0 (0%) – 20 (20%)
The response
inaccurately and
vaguely explains
how to improve
the patient’s drug
therapy plan, or is
missing.
The response may
include an
inaccurate and
vague explanation
to support the
recommended
improvements, or
is missing.
Written
Expression and
Formatting –
Paragraph
Development and
Organization:
Paragraphs make
clear points that
support well
developed ideas,
ow logically, and
demonstrate
continuity of
ideas. Sentences
are carefully
focused–neither
long and rambling
nor short and
lacking substance.
5 (5%) – 5 (5%)
Paragraphs and
sentences follow
writing standards
for ow,
continuity, and
clarity.
4 (4%) – 4 (4%)
Paragraphs and
sentences follow
writing standards
for ow,
continuity, and
clarity 80% of the
time.
3.5 (3.5%) – 3.5
(3.5%)
Paragraphs and
sentences follow
writing standards
for ow,
continuity, and
clarity 60%–79% of
the time.
0 (0%) – 3 (3%)
Paragraphs and
sentences follow
writing standards
for ow,
continuity, and
clarity less than
60% of the time.
Written
Expression and
Formatting –
English writing
standards:
Correct grammar,
mechanics, and
proper
punctuation
5 (5%) – 5 (5%)
Uses correct
grammar, spelling,
and punctuation
with no errors
4 (4%) – 4 (4%)
Contains a few (1–
2) grammar,
spelling, and
punctuation
errors
3.5 (3.5%) – 3.5
(3.5%)
Contains several
(3–4) grammar,
spelling, and
punctuation
errors
0 (0%) – 3 (3%)
Contains many (≥
5) grammar,
spelling, and
punctuation
errors that
interfere with the
reader’s
understanding
Excellent Good Fair Poor
Written
Expression and
Formatting – The
paper follows
correct APA
format for title
page, headings,
font,
spacing, margins,
indentations, page
numbers, running
head,
parenthetical/intext citations, and
reference list.
5 (5%) – 5 (5%)
Uses correct APA
format with no
errors
4 (4%) – 4 (4%)
Contains a few (1–
2) APA format
errors
3.5 (3.5%) – 3.5
(3.5%)
Contains several
(3–4) APA format
errors
0 (0%) – 3 (3%)
Contains many (≥
5) APA format
errors
Total Points: 100

Uncategorized
All Rights Reserved, Essaysland.com
Disclaimer: